Serum concentrations of procalcitonin after cardiac surgery.
作者： Cristina Prat , Pilar Ricart , Xavier Ruyra , Josep Domínguez , Jordi Morillas
DOI: 10.1111/J.1540-8191.2008.00658.X
关键词: Systemic inflammatory response syndrome 、 Prospective cohort study 、 Anesthesia 、 Valve replacement 、 Procalcitonin 、 Population 、 Intensive care unit 、 Cardiopulmonary bypass 、 Surgery 、 Cardiac surgery 、 Medicine
摘要: Abstract Background and Aim: Monitorization of complications in patients underlying cardiac surgery may be difficult because cardiopulmonary bypass (CPB) can lead to a systemic inflammatory response syndrome exposure blood nonphysiological surfaces. The purpose the study was establish baseline levels procalcitonin (PCT) after our population order analyze possible induction that might interfere with diagnosis infection by PCT. Methods: Serum samples from undergoing coronary artery grafting or valve replacement were collected at time admission intensive care unit, as well first second postoperative days. Patients followed for development complications. PCT measured immunoluminometric assay. Results: mean values significantly higher day all groups except control group. No increased found related neither duration CPB, nor aortic clamping. Only who presented had immediately (p = 0.004), < 0.0001), 0.0001) respect those recovered uneventfully. Conclusions: A slight transient increase observed surgery. Significant elevation only when present.
sci-hub.se 参考文章(41)
Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thoracic and Cardiovascular Surgeon. ,vol. 51, pp. 322- 326 ,(2003) , 10.1055/S-2003-45425
D.A. Rocke, S.L. Gaffin, M.T. Wells, Y. Koen, J.G. Brock-Utine, Endotoxemia associated with cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery. ,vol. 93, pp. 832- 837 ,(1987) , 10.1016/S0022-5223(19)37043-6
Guillaume Monneret, Maud Arpin, Fabienne Venet, Karim Maghni, Anne-Lise Debard, Alexandre Pachot, Alain Lepape, Jacques Bienvenu, Calcitonin gene related peptide and N -procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils Intensive Care Medicine. ,vol. 29, pp. 923- 928 ,(2003) , 10.1007/S00134-003-1759-2
Christoph Sponholz, Yasser Sakr, Konrad Reinhart, Frank Brunkhorst, Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Critical Care. ,vol. 10, pp. 1- 11 ,(2006) , 10.1186/CC5067
Hani A. Hennein, Hailu Ebba, Jorge L. Rodriguez, Scot H. Merrick, Fraser M. Keith, Merrill H. Bronstein, Jacqueline M. Leung, Dennis T. Mangano, Lazar J. Greenfield, J.Scott Rankin, Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization The Journal of Thoracic and Cardiovascular Surgery. ,vol. 108, pp. 626- 635 ,(1994) , 10.1016/S0022-5223(94)70286-1
Kenneth L Becker, ES Nylen, RH Snider, B Müller, JC White, Immunoneutralization of procalcitonin as therapy of sepsis. Journal of Endotoxin Research. ,vol. 9, pp. 367- 374 ,(2003) , 10.1177/09680519030090061001
W. Karzai, M. Oberhoffer, A. Meier-Hellmann, K. Reinhart, Procalcitonin — A new indicator of the systemic response to severe infections Infection. ,vol. 25, pp. 329- 334 ,(1997) , 10.1007/BF01740811
Attila Balog, Imre Ocsovszki, Yvette Mándi, Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes. Immunology Letters. ,vol. 84, pp. 199- 203 ,(2002) , 10.1016/S0165-2478(02)00158-X
K. Reinhart, W. Karzai, M. Meisner, Procalcitonin as a marker of the systemic inflammatory response to infection Intensive Care Medicine. ,vol. 26, pp. 1193- 1200 ,(2000) , 10.1007/S001340000624
O. Mimoz, A. R. Edouard, K. Samii, J. F. Benoist, M. Assicot, C. Bohuon, Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome Intensive Care Medicine. ,vol. 24, pp. 185- 188 ,(1998) , 10.1007/S001340050543